Startseite Acetylcholinesterase activity and bone biochemical markers in premature and full-term neonates
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Acetylcholinesterase activity and bone biochemical markers in premature and full-term neonates

  • Charalampos Dokos ORCID logo EMAIL logo , Christos Tsakalidis , Kyriakoula Manaridou und George Koliakos
Veröffentlicht/Copyright: 14. November 2018

Abstract

Background

Almost 30% of the premature infants have low body weight and bone mineral density due to prematurity. There is no consensus of screening premature neonates for metabolic bone disease; therefore, it is important to investigate the use of bone biochemical parameters. Latest studies involved the activity of acetylcholinesterase as a mediator in bone remodeling. It is hypothesized that there is a possible correlation of bone biochemical biomarkers and acetylcholinesterase (AChE) activity in premature infants.

Methods

We studied 50 neonates (26 preterm with gestational age <32 weeks, 24 full-term). Clinical data (sex, gestational week) and anthropometric parameters (body weight) were recorded. We directly measured the bone biochemical markers in serum such as alkaline phosphatase (ALP), calcium (Ca), phosphorus (P), magnesium (Mg) and parathyroid hormone (PTH). In addition, we measured the AChE activity.

Results

ALP and parathyroid hormone levels were higher, but Ca, P and AChE were lower in premature neonates group compared with full-term ones. There is a significant positive correlation of gestational age with body weight, Ca and AChE. A significant negative correlation was observed for ALP and PTH with gestational age.

Conclusions

We found a gestational age-related increase of AChE activity. There were significant relationships between AChE activity with P and PTH.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Βozzetti V, Tagliabue P. Metabolic bone disease in preterm newborn: an update on nutritional issues. Ital J Pediatr 2009;35:20.10.1186/1824-7288-35-20Suche in Google Scholar PubMed

2. Koo WW, Sherman R, Succop P, Krug-Wispe S, Tsang RC, et al. Fractures and rickets in very low birth weight infants: conservative management and outcome. J Pediatr Orthop 1989;9:326–30.10.1097/01202412-198909030-00012Suche in Google Scholar PubMed

3. Yeşiltepe Mutlu G, Kırmızıbekmez H, Ozsu E, Er I, Hatun S. Metabolic bone disease of prematurity: report of four cases. J Clin Res Pediatr Endocrinol 2014;6:111–5.10.4274/jcrpe.1282Suche in Google Scholar PubMed

4. Dokos C, Tsakalidis C, Tragiannidis A, Rallis D. Inside the “fragile” infant: pathophysiology, molecular background, risk factors and investigation of neonatal osteopenia. Clin Cases Miner Bone Metab 2013;10:86–90.Suche in Google Scholar PubMed

5. Paraoanu LE, Layer PG. Acetylcholinesterase in cell adhesion, neurite growth and network formation. FEBS J 2008;275:618–24.10.1111/j.1742-4658.2007.06237.xSuche in Google Scholar PubMed

6. Sato T, Abe T, Chida D, Nakamoto N, Hori N, et al. Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts. FEBS Lett 2010;584:817–24.10.1016/j.febslet.2010.01.001Suche in Google Scholar PubMed

7. Genever PG, Birch MA, Brown E, Skerry TM. Osteoblast-derived acetylcholinesterase: a novel mediator of cell-matrix interactions in bone? Bone 1999;24:297–303.10.1016/S8756-3282(98)00187-2Suche in Google Scholar PubMed

8. Beyers N, Alheit B, Taljaard JF, Hall JM, Hough SF. High turnover osteopenia in preterm babies. Bone 1994;15:5–13.10.1016/8756-3282(94)90884-2Suche in Google Scholar PubMed

9. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.10.1016/0006-2952(61)90145-9Suche in Google Scholar PubMed

10. Harrison CM, Johnson K, McKechnie E. Osteopenia of prematurity: a national survey and review of practice. Acta Paediatr 2008;97:407–13.10.1111/j.1651-2227.2007.00721.xSuche in Google Scholar PubMed

11. Mitchell SM, Rogers SP, Hicks PD, Hawthorne KM, Parker BR, et al. High frequencies of elevated alkaline phosphatase activity and rickets exist in extremely low birth weight infants despite current nutritional support. BMC Pediatr 2009;9:47.10.1186/1471-2431-9-47Suche in Google Scholar PubMed PubMed Central

12. Lucas A, Brooke OG, Baker BA, Bishop N, Morley R. High alkaline phosphatase activity and growth in preterm neonates. Arch Dis Child 1989;64:902–9.10.1136/adc.64.7_Spec_No.902Suche in Google Scholar PubMed

13. Anderson HC. Matrix vesicles and calcification. Curr Rheumatol Rep 2003;5:222–6.10.1007/s11926-003-0071-zSuche in Google Scholar PubMed

14. Bishop N. Bone disease in preterm infants. Arch Dis Child 1989;64:1403–9.10.1136/adc.64.10_Spec_No.1403Suche in Google Scholar PubMed

15. Yeh JK, Liu CC, Aloia JF. Effects of exercise and immobilization on bone formation and resorption in young rats. Am J Physiol 1993;264:E182–9.10.1152/ajpendo.1993.264.2.E182Suche in Google Scholar PubMed

16. Moreira A, Swischuk L, Malloy M, Mudd D, Blanco C, et al. Parathyroid hormone as a marker for metabolic bone disease of prematurity. J Perinatol 2014;34:787–91.10.1038/jp.2014.97Suche in Google Scholar PubMed

17. Papantoniou NE, Papapetrou PD, Antsaklis AJ, Kontoleon PE, Mesogitis SA, et al. Circulating levels of immunoreactive parathyroid hormone-related protein and intact parathyroid hormone in human fetuses and newborns. Eur J Endocrinol 1996;134:437–42.10.1530/eje.0.1340437Suche in Google Scholar PubMed

18. Spieker J, Ackermann A, Salfelder A, Vogel-Höpker A, Layer PG. Acetylcholinesterase regulates skeletal in ovo development of chicken limbs by ACh-dependent and -independent mechanisms. PLoS One 2016;11:e0161675.10.1371/journal.pone.0161675Suche in Google Scholar PubMed PubMed Central

Received: 2018-05-08
Accepted: 2018-10-15
Published Online: 2018-11-14
Published in Print: 2018-12-19

©2018 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 28.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0426/pdf
Button zum nach oben scrollen